Stem cell clinic to ‘vigorously defend’ US FDA lawsuit – BioPharma-Reporter.com
BioPharma-Reporter.com |
Stem cell clinic to 'vigorously defend' US FDA lawsuit
BioPharma-Reporter.com The lawsuit seeks to stop USRM and related parties from performing a surgical procedure using stem cells from autologous adipose tissue. Dr. Kristin Comella, chief science officer of US Stem Cell, told us in a statement: “My entire career has been … Where bioengineering and stem cell science meet, and thrive Mapping the Genes Responsible for Pluripotency [Doctors with Patents] SNUH professor pursues stem cell research for real-life therapiesKim Hyo-soo pushes forward … |
